Literature DB >> 15926407

Treatment options for prostate cancer: evaluating the evidence.

Vibha Bhatnagar1, Robert M Kaplan.   

Abstract

Controversy surrounds the management options for localized prostate cancer-conservative management, prostatectomy, and radiation. Choosing among these options is difficult because of long-term side effects that include sexual, urinary, and bowel dysfunction. Some recent studies suggest that patients who have chosen treatment (i.e., radical prostatectomy or radiation) have longer disease-free survival compared with patients who have chosen conservative management (i.e., watchful waiting). However, several biases may artificially enhance the perceived value of treatment and make the interpretation of studies on treatment outcomes difficult. Sources of bias include lead time, length time, and patient selection. Because of the uncertain efficacy of management options and the risk of long-term treatment complications, family physicians need to engage their patients in the decision-making process.

Entities:  

Mesh:

Year:  2005        PMID: 15926407

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  7 in total

1.  [Primum nil nocere].

Authors:  C Roloff
Journal:  Urologe A       Date:  2015-10       Impact factor: 0.639

2.  Morusin induces cell death through inactivating STAT3 signaling in prostate cancer cells.

Authors:  Sung-Lyul Lim; Sang-Yoon Park; Sukmin Kang; Dain Park; Sung-Hoon Kim; Jae-Young Um; Hyeung-Jin Jang; Jun-Hee Lee; Chul-Ho Jeong; Jung-Hee Jang; Kwang Seok Ahn; Seok-Geun Lee
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

3.  Development of a scale to assess patient misperceptions about treatment choices for localized prostate cancer.

Authors:  Hind A Beydoun; Ravinder Mohan; May A Beydoun; John Davis; Raymond Lance; Paul Schellhammer
Journal:  BJU Int       Date:  2010-02-11       Impact factor: 5.588

4.  Effect of alpha1-adrenoceptor antagonist exposure on prostate cancer incidence: an observational cohort study.

Authors:  Andrew M Harris; Bradley W Warner; John M Wilson; Aaron Becker; Randall G Rowland; William Conner; Matthew Lane; Kimberly Kimbler; Eric B Durbin; Andre T Baron; Natasha Kyprianou
Journal:  J Urol       Date:  2007-09-17       Impact factor: 7.450

5.  [Survival of patients diagnosed with prostate cancer and monitored in primary care].

Authors:  Gabriel J Díaz Grávalos; Gerardo Palmeiro Fernández; Inmaculada Casado Górriz; Margarita Arandia García; Susana Alvarez Araújo; Mónica González Dacosta
Journal:  Aten Primaria       Date:  2007-11       Impact factor: 1.137

Review 6.  Prostate cancer: issues in psychosomatic medicine.

Authors:  Keira Chism; Elisabeth J S Kunkel
Journal:  Curr Psychiatry Rep       Date:  2009-06       Impact factor: 5.285

7.  Efficacy of using three-tesla magnetic resonance imaging diagnosis of capsule invasion for decision-making about neurovascular bundle preservation in robotic-assisted radical prostatectomy.

Authors:  Kazushi Tanaka; Katsumi Shigemura; Mototsugu Muramaki; Satoru Takahashi; Hideaki Miyake; Masato Fujisawa
Journal:  Korean J Urol       Date:  2013-07-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.